“Orthomyxoviridae”的意思、由来-开放百科全书

The Orthomyxoviruses (ὀρθός, orthós, Greek for "straight"; μύξα, mýxa, Greek for "mucus")^[1] are a family of RNA viruses that includes seven genera: Influenza virus A, Influenza virus B, Influenza virus C, Influenza virus D, Isavirus, Thogotovirus, and Quaranjavirus. The first four genera contain viruses that cause influenza in vertebrates, including birds (see also avian influenza), humans, and other mammals. Isaviruses infect salmon; the thogotoviruses are arboviruses, infecting vertebrates and invertebrates, such as ticks and mosquitoes.^[2]^[3]^[4]

The four genera of Influenza virus, which are identified by antigenic differences in their nucleoprotein and matrix protein, infect vertebrates as follows:

Classification

In a phylogenetic-based taxonomy, the category "RNA virus" includes the category "negative-sense ssRNA virus", which includes the Order "Mononegavirales", and the Family "Orthomyxovirus" (among others). The genera-associated species and serotypes of Orthomyxovirus are shown in the following table.

ICTV Taxonomy

Types

There are four genera of influenza virus, each containing only a single species, or type. Influenza A and C infect a variety of species, while influenza B almost exclusively infects humans, and influenza D infects cattle and pigs.^[8]^[9]^[10]

Influenza A

Influenza A viruses are further classified, based on the viral surface proteins hemagglutinin (HA or H) and neuraminidase (NA or N). Sixteen H subtypes (or serotypes) and nine N subtypes of influenza A virus have been identified.

Further variation exists; thus, specific influenza strain isolates are identified by a standard nomenclature specifying virus type, geographical location where first isolated, sequential number of isolation, year of isolation, and HA and NA subtype.^[11]^[12]

The type A viruses are the most virulent human pathogens among the three influenza types and cause the most severe disease. The serotypes that have been confirmed in humans, ordered by the number of known human pandemic deaths, are:

Influenza B

Influenza B virus is almost exclusively a human pathogen, and is less common than influenza A. The only other animal known to be susceptible to influenza B infection is the seal.^[24] This type of influenza mutates at a rate 2–3 times lower than type A^[25] and consequently is less genetically diverse, with only one influenza B serotype.^[8] As a result of this lack of antigenic diversity, a degree of immunity to influenza B is usually acquired at an early age. However, influenza B mutates enough that lasting immunity is not possible.^[26] This reduced rate of antigenic change, combined with its limited host range (inhibiting cross species antigenic shift), ensures that pandemics of influenza B do not occur.^[27]

Influenza C

The influenza C virus infects humans and pigs, and can cause severe illness and local epidemics.^[28] However, influenza C is less common than the other types and usually seems to cause mild disease in children.^[29]^[30]

Influenza D

This is a genus that was classified in 2016, the members of which were first isolated in 2011.^[31] This genus appears to be most closely related to Influenza C, from which it diverged several hundred years ago.^[32] There are at least two strains of this genus in extant.^[33] The main hosts appear to be cattle, but this virus has seen to infect pigs as well.

Morphology

The virion is pleomorphic; the envelope can occur in spherical and filamentous forms. In general, the virus's morphology is ellipsoidal with particles 80 to 120 nm in diameter, or filamentous virions 80–120 nm in diameter and up to 20 µm long.^[34] There are some 500 distinct spike-like surface projections of the envelope each projecting 10 to 14 nm from the surface with varying surface densities.

The major glycoprotein (HA) is interposed irregularly by clusters of neuraminidase (NA), with a ratio of HA to NA of about 4–5 to 1.

Cholesterol-laden membranes with protruding glycoproteins enclose the nucleocapsids; nucleoproteins of different size classes with a loop at each end; the arrangement within the virion is uncertain. The ribonuclear proteins are filamentous and fall in the range of 50 to 130 nm long and 9 to 15 nm in diameter. They have a helical symmetry.

Genome

Viruses of this family contain 6 to 8 segments of linear negative-sense single stranded RNA.^[35]

The total genome length is 12000–15000 nucleotides (nt). The size of each segment is as follows:

The Genome sequence has terminal repeated sequences; repeated at both ends. Terminal repeats at the 5'-end 12–13 nucleotides long. Nucleotide sequences of 3'-terminus identical; the same in genera of same family; most on RNA (segments), or on all RNA species. Terminal repeats at the 3'-end 9–11 nucleotides long. Encapsidated nucleic acid is solely genomic. Each virion may contain defective interfering copies. In Influenza A (H1N1) PB1-F2 is produced from an alternative reading frame in PB1. The M and NS genes produce 2 different genes via alternative splicing.^[36]

Structure

The following applies for Influenza A viruses, although other influenza strains are very similar in structure:^[37]

The influenza A virus particle or virion is 80–120 nm in diameter, usually producing both ellipsoidal, baciliform, and filamentous particles.^[38]^[39]^[40] Unusually for a virus, the influenza A genome is not a single piece of nucleic acid; instead, it contains eight pieces of segmented negative-sense RNA (13.5 kilobases total), which encode 11 proteins (HA, NA, NP, M1, M2, NS1, NEP, PA, PB1, PB1-F2, PB2).^[41] The best-characterised of these viral proteins are hemagglutinin and neuraminidase, two large glycoproteins found on the outside of the viral particles. Neuraminidase is an enzyme involved in the release of progeny virus from infected cells, by cleaving sugars that bind the mature viral particles. By contrast, hemagglutinin is a lectin that mediates binding of the virus to target cells and entry of the viral genome into the target cell.^[42] The hemagglutinin (H) and neuraminidase (N) proteins are targets for antiviral drugs.^[43] These proteins are also recognised by antibodies, i.e. they are antigens.^[16] The responses of antibodies to these proteins are used to classify the different serotypes of influenza A viruses, hence the H and N in H5N1.

Replication cycle

Typically, influenza is transmitted from infected mammals through the air by coughs or sneezes, creating aerosols containing the virus, and from infected birds through their droppings. Influenza can also be transmitted by saliva, nasal secretions, feces and blood. Infections occur through contact with these bodily fluids or with contaminated surfaces. Out of a host, flu viruses can remain infectious for about one week at human body temperature, over 30 days at {{convert|0|°C}}, and indefinitely at very low temperatures (such as lakes in northeast Siberia). They can be inactivated easily by disinfectants and detergents.^[44]^[45]^[46]

The viruses bind to a cell through interactions between its hemagglutinin glycoprotein and sialic acid sugars on the surfaces of epithelial cells in the lung and throat (Stage 1 in infection figure).^[47] The cell imports the virus by endocytosis. In the acidic endosome, part of the haemagglutinin protein fuses the viral envelope with the vacuole's membrane, releasing the viral RNA (vRNA) molecules, accessory proteins and RNA-dependent RNA polymerase into the cytoplasm (Stage 2).^[48] These proteins and vRNA form a complex that is transported into the cell nucleus, where the RNA-dependent RNA polymerase begins transcribing complementary positive-sense cRNA (Steps 3a and b).^[49] The cRNA is either exported into the cytoplasm and translated (step 4), or remains in the nucleus. Newly synthesised viral proteins are either secreted through the Golgi apparatus onto the cell surface (in the case of neuraminidase and hemagglutinin, step 5b) or transported back into the nucleus to bind vRNA and form new viral genome particles (step 5a). Other viral proteins have multiple actions in the host cell, including degrading cellular mRNA and using the released nucleotides for vRNA synthesis and also inhibiting translation of host-cell mRNAs.^[50]

Negative-sense vRNAs that form the genomes of future viruses, RNA-dependent RNA transcriptase, and other viral proteins are assembled into a virion. Hemagglutinin and neuraminidase molecules cluster into a bulge in the cell membrane. The vRNA and viral core proteins leave the nucleus and enter this membrane protrusion (step 6). The mature virus buds off from the cell in a sphere of host phospholipid membrane, acquiring hemagglutinin and neuraminidase with this membrane coat (step 7).^[51] As before, the viruses adhere to the cell through hemagglutinin; the mature viruses detach once their neuraminidase has cleaved sialic acid residues from the host cell.^[47] After the release of new influenza virus, the host cell dies.

Orthomyxoviridae viruses are one of two RNA viruses that replicate in the nucleus (the other being retroviridae). This is because the machinery of orthomyxo viruses cannot make their own mRNAs. They use cellular RNAs as primers for initiating the viral mRNA synthesis in a process known as cap snatching.^[52] Once in the nucleus, the RNA Polymerase Protein PB2 finds a cellular pre-mRNA and binds to its 5' capped end. Then RNA Polymerase PA cleaves off the cellular mRNA near the 5' end and uses this capped fragment as a primer for transcribing the rest of the viral RNA genome in viral mRNA.^[53] This is due to the need of mRNA to have a 5' cap in order to be recognized by the cell's ribosome for translation.

Since RNA proofreading enzymes are absent, the RNA-dependent RNA transcriptase makes a single nucleotide insertion error roughly every 10 thousand nucleotides, which is the approximate length of the influenza vRNA. Hence, nearly every newly manufactured influenza virus will contain a mutation in its genome.^[54] The separation of the genome into eight separate segments of vRNA allows mixing (reassortment) of the genes if more than one variety of influenza virus has infected the same cell (superinfection). The resulting alteration in the genome segments packaged into viral progeny confers new behavior, sometimes the ability to infect new host species or to overcome protective immunity of host populations to its old genome (in which case it is called an antigenic shift).^[16]

Viability and disinfection

Mammalian influenza viruses tend to be labile, but can survive several hours in mucus.^[55] Avian influenza virus can survive for 100 days in distilled water at room temperature, and 200 days at {{convert|17|°C}}. The avian virus is inactivated more quickly in manure, but can survive for up to 2 weeks in feces on cages. Avian influenza viruses can survive indefinitely when frozen.^[55] Influenza viruses are susceptible to bleach, 70% ethanol, aldehydes, oxidizing agents, and quaternary ammonium compounds. They are inactivated by heat of {{convert|133|°F}} for minimum of 60 minutes, as well as by low pH <2.^[55]

Vaccination and prophylaxis

Vaccines and drugs are available for the prophylaxis and treatment of influenza virus infections. Vaccines are composed of either inactivated or live attenuated virions of the H1N1 and H3N2 human influenza A viruses, as well as those of influenza B viruses. Because the antigenicities of the wild viruses evolve, vaccines are reformulated annually by updating the seed strains.

However, when the antigenicities of the seed strains and wild viruses do not match, vaccines fail to protect the vaccinees. In addition, even when they do match, escape mutants are often generated. Drugs available for the treatment of influenza include Amantadine and Rimantadine, which inhibit the uncoating of virions by interfering with M2, and Oseltamivir (marketed under the brand name Tamiflu), Zanamivir, and Peramivir, which inhibit the release of virions from infected cells by interfering with NA. However, escape mutants are often generated for the former drug and less frequently for the latter drug.^[56]

See also

References

1. ^[https://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_ortho.htm International Committee on Taxonomy of Viruses] Index of Viruses — Orthomyxovirus (2006). In: ICTVdB—The Universal Virus Database, version 4. Büchen-Osmond, C (Ed), Columbia University, New York.
2. ^{{cite journal |vauthors=Jones LD, Nuttall PA |title=Non-viraemic transmission of Thogoto virus: influence of time and distance |journal=Trans. R. Soc. Trop. Med. Hyg. |volume=83 |issue=5 |pages=712–14 |year=1989 |pmid=2617637|doi=10.1016/0035-9203(89)90405-7}}
3. ^{{cite web | url = http://www.nimr.mrc.ac.uk/MillHillEssays/1999/isa.htm | title = Infectious Salmon Anaemia | accessdate = 2007-09-14 | first = Barry | last = Ely | name-list-format = vanc | year = 1999 | work = Mill Hill Essays | publisher = National Institute for Medical Research |archiveurl = https://web.archive.org/web/20070824184945/http://www.nimr.mrc.ac.uk/MillHillEssays/1999/isa.htm |archivedate = 2007-08-24}}
4. ^{{cite journal |vauthors=Raynard RS, Murray AG, Gregory A | title = Infectious salmon anaemia virus in wild fish from Scotland | journal = Dis. Aquat. Org. | volume = 46 | issue = 2 | pages = 93–100 | year = 2001 | pmid = 11678233| doi = 10.3354/dao046093}}
5. ^{{cite journal | vauthors = Biere B, Bauer B, Schweiger B | title = Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR | journal = Journal of Clinical Microbiology | volume = 48 | issue = 4 | pages = 1425–7 | date = April 2010 | pmid = 20107085 | pmc = 2849545 | doi = 10.1128/JCM.02116-09 | url = http://edoc.rki.de/oa/articles/re8YOWTg09z5Q/PDF/28qDm9v6bEBxw.pdf }}
6. ^{{Citation | title = ICTV Taxonomy History | publisher = ICTV | year = 2014 | url = http://www.ictvonline.org/taxonomyHistory.asp?taxnode_id=20132316&taxa_name=Quaranjavirus | accessdate = 6 June 2006 }}
7. ^{{cite web|last1=ICTV|title=Virus Taxonomy: 2014 Release|url=http://ictvonline.org/virusTaxonomy.asp|accessdate=15 June 2015}}
8. ^¹{{cite journal | vauthors = Hay A, Gregory V, Douglas A, Lin Y | title = The evolution of human influenza viruses | journal = Philos Trans R Soc Lond B Biol Sci | volume = 356 | issue = 1416 | pages = 1861–70 | date = Dec 29, 2001 | pmid = 11779385 | doi = 10.1098/rstb.2001.0999 | pmc = 1088562 }}
9. ^{{cite web | url = https://www.cdc.gov/flu/avian/ | title = Avian Influenza (Bird Flu) | accessdate = 2007-09-15 | publisher = Centers for Disease Control and Prevention }}
10. ^{{Cite journal|last=Kumar|first=Binod|last2=Asha|first2=Kumari|last3=Khanna|first3=Madhu|last4=Ronsard|first4=Larance|last5=Meseko|first5=Clement Adebajo|last6=Sanicas|first6=Melvin|date=April 2018|title=The emerging influenza virus threat: status and new prospects for its therapy and control|journal=Archives of Virology|volume=163|issue=4|pages=831–844|doi=10.1007/s00705-018-3708-y|issn=1432-8798|pmid=29322273}}
11. ^{{cite book |veditors=Atkinson W, Hamborsky J, McIntyre L, Wolfe S | title = Epidemiology and Prevention of Vaccine-Preventable Diseases | url = https://www.cdc.gov/vaccines/pubs/pinkbook/pink-chapters.htm | edition = 10th | year = 2007 | publisher = Centers for Disease Control and Prevention | location = Washington DC}}
12. ^{{cite web | url = http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/biofacts/avflu_human.html | title = Avian Influenza (Bird Flu): Implications for Human Disease | accessdate = 2007-09-14 | date = 2007-06-27 | publisher = Center for Infectious Disease Research & Policy, University of Minnesota}}
13. ^{{cite journal | pmid = 19524497 | doi=10.1016/j.cell.2009.05.032 | volume=137 | issue=6 | journal = Cell |date=June 2009 | title = Unraveling the Mystery of Swine Influenza Virus | pages=983–85 | vauthors=Wang TT, Palese P | author2-link=Peter Palese }}
14. ^{{cite journal | pmid = 19618626 | pmc=2720801 | volume=28 | issue=1 | journal = Rev. – Off. Int. Epizoot. | date=April 2009 | title = Pandemic influenza – including a risk assessment of H5N1 | pages=187–202 | vauthors= Taubenberger, JK, Morens, DM | doi=10.20506/rst.28.1.1879}}
15. ^{{cite journal |vauthors=Fouchier R, Schneeberger P, Rozendaal F, Broekman J, Kemink S, Munster V, Kuiken T, Rimmelzwaan G, Schutten M, Van Doornum G, Koch G, Bosman A, Koopmans M, Osterhaus A | title = Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome | journal = Proc Natl Acad Sci USA | volume = 101 | issue = 5 | pages = 1356–61 | year = 2004 | pmid = 14745020 | doi = 10.1073/pnas.0308352100 | pmc = 337057|bibcode = 2004PNAS..101.1356F }}
16. ^¹²{{cite journal | vauthors = Hilleman MR | title = Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control | journal = Vaccine | volume = 20 | issue = 25–26 | pages = 3068–87 | date = August 2002 | pmid = 12163258 | doi = 10.1016/S0264-410X(02)00254-2 }}
17. ^{{cite journal | vauthors = Potter CW | title = A history of influenza | journal = Journal of Applied Microbiology | volume = 91 | issue = 4 | pages = 572–9 | date = October 2001 | pmid = 11576290 | doi = 10.1046/j.1365-2672.2001.01492.x }}
18. ^{{cite web |url=http://www.who.int/csr/disease/influenza/pandemic10things/en/index.html |publisher=World Health Organization |date=14 October 2005 |title=Ten things you need to know about pandemic influenza|access-date=26 September 2009 |archive-url=https://web.archive.org/web/20090923231756/http://www.who.int/csr/disease/influenza/pandemic10things/en/index.html |archive-date=23 September 2009}}
19. ^{{cite journal |vauthors=Valleron AJ, Cori A, Valtat S, Meurisse S, Carrat F, Boëlle PY |title=Transmissibility and geographic spread of the 1889 influenza pandemic |journal=Proc. Natl. Acad. Sci. USA |volume=107 |issue=19 |pages=8778–81 |date=May 2010 |pmid=20421481 |doi=10.1073/pnas.1000886107 |pmc=2889325|bibcode = 2010PNAS..107.8778V }}
20. ^{{cite journal |vauthors=Mills CE, Robins JM, Lipsitch M |author2-link=James Robins |title=Transmissibility of 1918 pandemic influenza |journal=Nature |volume=432 |issue=7019 |pages=904–06 |date=December 2004 |pmid=15602562 |doi=10.1038/nature03063 |bibcode = 2004Natur.432..904M }}
21. ^{{cite journal |author=Donaldson LJ |title=Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study |journal=BMJ |volume=339 |issue= |pages=b5213 |year=2009 |pmid=20007665 |pmc=2791802 |doi=10.1136/bmj.b5213 |name-list-format=vanc|author2=Rutter PD |author3=Ellis BM |display-authors=3 |last4=Greaves |first4=F. E C |last5=Mytton |first5=O. T |last6=Pebody |first6=R. G |last7=Yardley |first7=I. E}}
22. ^{{cite web |url= http://ecdc.europa.eu/en/healthtopics/Documents/100118_Influenza_AH1N1_Situation_Report_0900hrs.pdf |title=ECDC Daily Update – Pandemic (H1N1) 2009 – January 18, 2010|publisher=European Centre for Disease Prevention and Control|date=2010-01-18|accessdate=2010-01-18|deadurl=yes|archiveurl=https://web.archive.org/web/20100122162136/http://www.ecdc.europa.eu/en/healthtopics/Documents/100118_Influenza_AH1N1_Situation_Report_0900hrs.pdf|archivedate=January 22, 2010}}
23. ^{{cite journal | vauthors = Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Feikin DR, Fowler KB, Gordon A, Hien NT, Horby P, Huang QS, Katz MA, Krishnan A, Lal R, Montgomery JM, Mølbak K, Pebody R, Presanis AM, Razuri H, Steens A, Tinoco YO, Wallinga J, Yu H, Vong S, Bresee J, Widdowson MA | title = Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study | journal = The Lancet. Infectious Diseases | volume = 12 | issue = 9 | pages = 687–95 | date = September 2012 | pmid = 22738893 | doi = 10.1016/S1473-3099(12)70121-4 | url = https://zenodo.org/record/1260250 | type = Submitted manuscript }}
24. ^{{cite journal | vauthors = Osterhaus AD, Rimmelzwaan GF, Martina BE, Bestebroer TM, Fouchier RA | title = Influenza B virus in seals | journal = Science | volume = 288 | issue = 5468 | pages = 1051–3 | date = May 2000 | pmid = 10807575 | doi = 10.1126/science.288.5468.1051 | bibcode = 2000Sci...288.1051O }}
25. ^{{cite journal | vauthors = Nobusawa E, Sato K | title = Comparison of the mutation rates of human influenza A and B viruses | journal = Journal of Virology | volume = 80 | issue = 7 | pages = 3675–8 | date = April 2006 | pmid = 16537638 | pmc = 1440390 | doi = 10.1128/JVI.80.7.3675-3678.2006 }}
26. ^{{cite journal | vauthors = Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y | title = Evolution and ecology of influenza A viruses | journal = Microbiological Reviews | volume = 56 | issue = 1 | pages = 152–79 | date = March 1992 | pmid = 1579108 | pmc = 372859 | url = http://mmbr.asm.org/cgi/pmidlookup?view=long&pmid=1579108 }}
27. ^{{cite journal | vauthors = Zambon MC | title = Epidemiology and pathogenesis of influenza | journal = The Journal of Antimicrobial Chemotherapy | volume = 44 Suppl B | issue = Suppl B | pages = 3–9 | date = November 1999 | pmid = 10877456 | doi = 10.1093/jac/44.suppl_2.3 }}
28. ^{{cite journal |vauthors=Matsuzaki Y, Sugawara K, Mizuta K, Tsuchiya E, Muraki Y, Hongo S, Suzuki H, Nakamura K | title = Antigenic and genetic characterization of influenza C viruses which caused two outbreaks in Yamagata City, Japan, in 1996 and 1998 |pmc=153379 |url=http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=11825952 | journal = J Clin Microbiol | volume = 40 | issue = 2 | pages = 422–29 | year = 2002 | pmid = 11825952 | doi = 10.1128/JCM.40.2.422-429.2002}}
29. ^{{cite journal |vauthors=Matsuzaki Y, Katsushima N, Nagai Y, Shoji M, Itagaki T, Sakamoto M, Kitaoka S, Mizuta K, Nishimura H | title = Clinical features of influenza C virus infection in children | journal = J Infect Dis | volume = 193 | issue = 9 | pages = 1229–35 | date=May 1, 2006 | pmid = 16586359 | doi = 10.1086/502973}}
30. ^{{cite journal |vauthors=Katagiri S, Ohizumi A, Homma M | title = An outbreak of type C influenza in a children's home | journal = J Infect Dis | volume = 148 | issue = 1 | pages = 51–56 |date=July 1983 | pmid = 6309999 | doi=10.1093/infdis/148.1.51}}
31. ^{{cite journal | vauthors = Hause BM, Ducatez M, Collin EA, Ran Z, Liu R, Sheng Z, Armien A, Kaplan B, Chakravarty S, Hoppe AD, Webby RJ, Simonson RR, Li F | title = Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses | journal = PLoS Pathogens | volume = 9 | issue = 2 | pages = e1003176 | date = February 2013 | pmid = 23408893 | pmc = 3567177 | doi = 10.1371/journal.ppat.1003176 }}
32. ^{{cite journal | vauthors = Sheng Z, Ran Z, Wang D, Hoppe AD, Simonson R, Chakravarty S, Hause BM, Li F | title = Genomic and evolutionary characterization of a novel influenza-C-like virus from swine | journal = Archives of Virology | volume = 159 | issue = 2 | pages = 249–55 | date = February 2014 | pmid = 23942954 | pmc = 5714291 | doi = 10.1007/s00705-013-1815-3 }}
33. ^{{cite journal | vauthors = Collin EA, Sheng Z, Lang Y, Ma W, Hause BM, Li F | title = Cocirculation of two distinct genetic and antigenic lineages of proposed influenza D virus in cattle | journal = Journal of Virology | volume = 89 | issue = 2 | pages = 1036–42 | date = January 2015 | pmid = 25355894 | pmc = 4300623 | doi = 10.1128/JVI.02718-14 }}
34. ^{{cite journal | vauthors = Noda T | title = Native morphology of influenza virions | journal = Frontiers in Microbiology | volume = 2 | pages = 269 | date = 2012-01-03 | pmid = 22291683 | pmc = 3249889 | doi = 10.3389/fmicb.2011.00269 }}
35. ^{{cite web|url=http://www.ictvdb.org/Ictv/index.htm|title=International Committee on Taxonomy of Viruses (ICTV)|publisher=}}
36. ^{{cite journal | vauthors = Bouvier NM, Palese P | title = The biology of influenza viruses | journal = Vaccine | volume = 26 Suppl 4 | issue = | pages = D49–53 | date = September 2008 | pmid = 19230160 | pmc = 3074182 | doi = 10.1016/j.vaccine.2008.07.039 }}
37. ^International Committee on Taxonomy of Viruses descriptions of: [https://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/46000000.htm Orthomyxoviridae] [https://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/46040000.htm Influenzavirus B] [https://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/00.046.0.02.htm Influenzavirus C]
38. ^{{cite journal | vauthors = Badham MD, Rossman JS | title = Filamentous Influenza Viruses | journal = Current Clinical Microbiology Reports | volume = 3 | issue = 3 | pages = 155–161 | date = September 2016 | pmid = 28042529 | pmc = 5198887 | doi = 10.1007/s40588-016-0041-7 }}
39. ^{{cite journal | vauthors = Noda T | title = Native morphology of influenza virions | language = English | journal = Frontiers in Microbiology | volume = 2 | pages = 269 | date = 2012 | pmid = 22291683 | pmc = 3249889 | doi = 10.3389/fmicb.2011.00269 }}
40. ^{{cite journal | vauthors = Dadonaite B, Vijayakrishnan S, Fodor E, Bhella D, Hutchinson EC | title = Filamentous influenza viruses | journal = The Journal of General Virology | volume = 97 | issue = 8 | pages = 1755–64 | date = August 2016 | pmid = 27365089 | pmc = 5935222 | doi = 10.1099/jgv.0.000535 }}
41. ^{{cite journal | vauthors = Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor J, Lipman DJ, Fraser CM, Taubenberger JK, Salzberg SL | title = Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution | journal = Nature | volume = 437 | issue = 7062 | pages = 1162–6 | date = October 2005 | pmid = 16208317 | doi = 10.1038/nature04239 | bibcode = 2005Natur.437.1162G }}
42. ^{{cite journal | vauthors = Suzuki Y | title = Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses | journal = Biological & Pharmaceutical Bulletin | volume = 28 | issue = 3 | pages = 399–408 | date = March 2005 | pmid = 15744059 | doi = 10.1248/bpb.28.399 }}
43. ^{{cite journal | vauthors = Wilson JC, von Itzstein M | title = Recent strategies in the search for new anti-influenza therapies | journal = Current Drug Targets | volume = 4 | issue = 5 | pages = 389–408 | date = July 2003 | pmid = 12816348 | doi = 10.2174/1389450033491019 }}
44. ^{{cite journal | vauthors = Suarez DL, Spackman E, Senne DA, Bulaga L, Welsch AC, Froberg K | title = The effect of various disinfectants on detection of avian influenza virus by real time RT-PCR | journal = Avian Diseases | volume = 47 | issue = 3 Suppl | pages = 1091–5 | year = 2003 | pmid = 14575118 | doi = 10.1637/0005-2086-47.s3.1091 }}
45. ^{{cite web | url = http://www.cidrap.umn.edu/cidrap/content/influenza/avianflu/biofacts/avflu_human.html | title = Avian Influenza (Bird Flu) Implications for Human Disease. Physical characteristics of influenza A viruses. | work = CIDRAP - Center for Infectious Disease Research and Policy | publisher = University of Minnesota }}
46. ^{{cite news |url=http://www.nzherald.co.nz/health/news/article.cfm?c_id=204&objectid=10413124 |title=Flu viruses 'can live for decades' on ice |date=November 30, 2006 |agency=Reuters |work=The New Zealand Herald |access-date=November 1, 2011}}
47. ^¹{{cite journal |vauthors=Wagner R, Matrosovich M, Klenk H | title = Functional balance between haemagglutinin and neuraminidase in influenza virus infections | journal = Rev Med Virol | volume = 12 | issue = 3 | pages = 159–66 |date=May–Jun 2002| pmid = 11987141 | doi = 10.1002/rmv.352}}
48. ^{{cite journal |vauthors=Lakadamyali M, Rust M, Babcock H, Zhuang X | title = Visualizing infection of individual influenza viruses | journal = Proc Natl Acad Sci USA | volume = 100 | issue = 16 | pages = 9280–85 | date=Aug 5, 2003 | pmid = 12883000 | doi = 10.1073/pnas.0832269100 | pmc = 170909|bibcode = 2003PNAS..100.9280L }}
49. ^{{cite journal |vauthors=Cros J, Palese P | title = Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses | journal = Virus Res | volume = 95 | issue = 1–2 | pages = 3–12 |date=September 2003 | pmid = 12921991 | doi = 10.1016/S0168-1702(03)00159-X}}
50. ^{{cite journal |vauthors=Kash J, Goodman A, Korth M, Katze M | title = Hijacking of the host-cell response and translational control during influenza virus infection | journal = Virus Res | volume = 119 | issue = 1 | pages = 111–20 |date=July 2006 | pmid = 16630668 | doi = 10.1016/j.virusres.2005.10.013}}
51. ^{{cite journal |vauthors=Nayak D, Hui E, Barman S | title = Assembly and budding of influenza virus | journal = Virus Res | volume = 106 | issue = 2 | pages = 147–65 |date=December 2004 | pmid = 15567494 | doi = 10.1016/j.virusres.2004.08.012}}
52. ^{{cite web|title=Cap Snatching|url=http://viralzone.expasy.org/all_by_protein/839.html|website=ViralZone|publisher=expasy|accessdate=11 September 2014}}
53. ^{{cite journal | vauthors = Dias A, Bouvier D, Crépin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RW | title = The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit | journal = Nature | volume = 458 | issue = 7240 | pages = 914–8 | date = April 2009 | pmid = 19194459 | doi = 10.1038/nature07745 | bibcode = 2009Natur.458..914D }}
54. ^{{cite journal | author = Drake J | title = Rates of spontaneous mutation among RNA viruses | journal = Proc Natl Acad Sci USA | volume = 90 | issue = 9 | pages = 4171–5 | date=May 1, 1993 | pmid = 8387212 | doi = 10.1073/pnas.90.9.4171 | pmc = 46468|bibcode = 1993PNAS...90.4171D }}
55. ^¹²{{cite web | first = Anna Rovid | last = Spickler | name-list-format = vanc | title = Influenza | url = http://www.cfsph.iastate.edu/Factsheets/pdfs/influenza.pdf | page = 7 | date = February 2016 | work = The Center for Food Security and Public Health | publisher = Iowa State University }}
56. ^{{cite journal | vauthors = Suzuki Y | title = Natural selection on the influenza virus genome | journal = Molecular Biology and Evolution | volume = 23 | issue = 10 | pages = 1902–11 | date = October 2006 | pmid = 16818477 | doi = 10.1093/molbev/msl050 }}